Join
Live feed
·
PRReleasevia Quantisnow
GSK plc logo
Spero Therapeutics Inc. logo

Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr

ByQuantisnow·Wall Street's wire, on your screen.
GSK· GSK plcSPRO· Spero Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GSK (GSK plc), SPRO (Spero Therapeutics Inc.) and more on Quantisnow.